Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the italian oncology group for clinical research
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 12, S125-S132
- https://doi.org/10.1016/0169-5002(95)00428-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1991
- A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer GroupCancer Chemotherapy and Pharmacology, 1990
- Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compareBritish Journal of Cancer, 1988
- Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1985
- Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.Journal of Clinical Oncology, 1985
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage SchedulesAnnals of Internal Medicine, 1981
- Survival with inoperable lung cancer.An integration of prognostic variables based on simple clinical criteriaCancer, 1977